ProQR Therapeutics (PRQR) Shares Outstanding (Weighted Average) (2021 - 2025)
ProQR Therapeutics (PRQR) has disclosed Shares Outstanding (Weighted Average) for 5 consecutive years, with $122.6 million as the latest value for Q4 2025.
- Quarterly Shares Outstanding (Weighted Average) rose 2563.49% to $122.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $122.6 million through Dec 2025, up 2563.49% year-over-year, with the annual reading at $122.6 million for FY2025, 2563.49% up from the prior year.
- Shares Outstanding (Weighted Average) hit $122.6 million in Q4 2025 for ProQR Therapeutics, up from $4.6 million in the prior quarter.
- In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $122.6 million in Q4 2025 to a low of $4.6 million in Q4 2024.
- Historically, Shares Outstanding (Weighted Average) has averaged $77.2 million across 5 years, with a median of $86.0 million in 2022.
- Biggest five-year swings in Shares Outstanding (Weighted Average): crashed 94.72% in 2024 and later skyrocketed 2563.49% in 2025.
- Year by year, Shares Outstanding (Weighted Average) stood at $85.6 million in 2021, then rose by 0.36% to $86.0 million in 2022, then grew by 1.41% to $87.2 million in 2023, then plummeted by 94.72% to $4.6 million in 2024, then surged by 2563.49% to $122.6 million in 2025.
- Business Quant data shows Shares Outstanding (Weighted Average) for PRQR at $122.6 million in Q4 2025, $4.6 million in Q4 2024, and $87.2 million in Q4 2023.